+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

From
From
From
Investigation Report on China's Lamivudine Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Lamivudine Market, 2018-2022

  • Report
  • September 2018
  • 30 Pages
  • China
From
Disease Analysis: HIV Pre-Exposure Prophylaxis (HIV PrEP) - Product Thumbnail Image

Disease Analysis: HIV Pre-Exposure Prophylaxis (HIV PrEP)

  • Report
  • April 2021
  • 47 Pages
  • Global
Cenicriviroc (Allergan/Takeda) Drug Overview 2019 - Product Thumbnail Image

Cenicriviroc (Allergan/Takeda) Drug Overview 2019

  • Report
  • July 2019
  • 14 Pages
  • Global
HIV Disease Coverage Forecast and Market Analysis to 2027 - Product Thumbnail Image

HIV Disease Coverage Forecast and Market Analysis to 2027

  • Drug Pipelines
  • June 2019
  • 579 Pages
  • Global
Cabotegravir/Rilpivirine Drug Overview 2019 - Product Thumbnail Image

Cabotegravir/Rilpivirine Drug Overview 2019

  • Report
  • June 2019
  • 14 Pages
  • Global
Prezista (darunavir; Johnson & Johnson) Drug Overview 2019 - Product Thumbnail Image

Prezista (darunavir; Johnson & Johnson) Drug Overview 2019

  • Report
  • June 2019
  • 21 Pages
  • Global
Africa HIV Treatment Drugs Market 2023-2027 - Product Thumbnail Image

Africa HIV Treatment Drugs Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Africa
From
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more